Laurent Bonnac - Publications

University of Minnesota, Twin Cities, Minneapolis, MN 

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Geraghty RJ, Aliota MT, Bonnac LF. Broad-Spectrum Antiviral Strategies and Nucleoside Analogues. Viruses. 13. PMID 33924302 DOI: 10.3390/v13040667  0.56
2019 Bonnac LF, Dreis CD, Geraghty RJ. Structure activity relationship, 6-modified purine riboside analogues to activate hSTING, stimulator of interferon genes. Bioorganic & Medicinal Chemistry Letters. 126819. PMID 31780305 DOI: 10.1016/J.Bmcl.2019.126819  0.56
2018 Qiu L, Patterson SE, Bonnac LF, Geraghty RJ. Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis. Plos Neglected Tropical Diseases. 12: e0006421. PMID 29672522 DOI: 10.1371/Journal.Pntd.0006421  0.56
2016 Rawson JM, Roth ME, Xie J, Daly MB, Clouser CL, Landman SR, Reilly CS, Bonnac L, Kim B, Patterson SE, Mansky LM. Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase. Bioorganic & Medicinal Chemistry. PMID 27117260 DOI: 10.1016/J.Bmc.2016.03.052  0.44
2016 Daly MB, Roth ME, Bonnac L, Maldonado JO, Xie J, Clouser CL, Patterson SE, Kim B, Mansky LM. Dual anti-HIV mechanism of clofarabine. Retrovirology. 13: 20. PMID 27009333 DOI: 10.1186/S12977-016-0254-0  0.44
2016 Rawson JM, Daly MB, Xie J, Clouser CL, Landman SR, Reilly CS, Bonnac L, Kim B, Patterson SE, Mansky LM. 5-azacytidine enhances the mutagenesis of HIV-1 by reduction to 5-aza-2'-deoxycytidine. Antimicrobial Agents and Chemotherapy. PMID 26833151 DOI: 10.1128/Aac.03084-15  0.44
2015 Rawson JM, Landman SR, Reilly CS, Bonnac L, Patterson SE, Mansky LM. Lack of Mutational Hot Spots during Decitabine-Mediated HIV-1 Mutagenesis. Antimicrobial Agents and Chemotherapy. 59: 6834-43. PMID 26282416 DOI: 10.1128/Aac.01644-15  0.44
2014 Dapp MJ, Bonnac L, Patterson SE, Mansky LM. Discovery of novel ribonucleoside analogs with activity against human immunodeficiency virus type 1. Journal of Virology. 88: 354-63. PMID 24155391 DOI: 10.1128/Jvi.02444-13  0.44
2014 Clouser CL, Bonnac L, Mansky LM, Patterson SE. Characterization of permeability, stability and anti-HIV-1 activity of decitabine and gemcitabine divalerate prodrugs. Antiviral Chemistry & Chemotherapy. 23: 223-30. PMID 23994876 DOI: 10.3851/Imp2682  0.44
2013 Bonnac LF, Mansky LM, Patterson SE. Structure-activity relationships and design of viral mutagens and application to lethal mutagenesis. Journal of Medicinal Chemistry. 56: 9403-14. PMID 23914828 DOI: 10.1021/Jm400653J  0.44
2013 Faramarzalian A, McLennan G, Bennett SL, Babsky A, Bansal N, Lieber M, Bonnac L, Pankiewicz K, Jayaram HN. Variability of apoptosis and response in N1-S1 rodent hepatomas to benzamide riboside and correlation to early changes in water apparent diffusion coefficient and sodium MR imaging. Journal of Vascular and Interventional Radiology : Jvir. 24: 894-900. PMID 23566523 DOI: 10.1016/J.Jvir.2013.02.011  0.44
2012 McLennan G, Bennett SL, Ju S, Babsky A, Bansal N, Shorten ML, Levitin S, Bonnac L, Panciewicz KW, Jayaram HN. Tumor response and apoptosis of N1-S1 rodent hepatomas in response to intra-arterial and intravenous benzamide riboside. Cardiovascular and Interventional Radiology. 35: 645-52. PMID 21431971 DOI: 10.1007/S00270-011-0140-Z  0.44
2011 Lee SE, Elphick LM, Kramer HB, Jones AM, Child ES, Anderson AA, Bonnac L, Suwaki N, Kessler BM, Gouverneur V, Mann DJ. The chemoselective one-step alkylation and isolation of thiophosphorylated cdk2 substrates in the presence of native cysteine. Chembiochem : a European Journal of Chemical Biology. 12: 633-40. PMID 21305681 DOI: 10.1002/Cbic.201000528  0.44
2010 Bonnac L, Lee SE, Giuffredi GT, Elphick LM, Anderson AA, Child ES, Mann DJ, Gouverneur V. Synthesis and O-phosphorylation of 3,3,4,4-tetrafluoroaryl-C-nucleoside analogues. Organic & Biomolecular Chemistry. 8: 1445-54. PMID 20204220 DOI: 10.1039/B922442D  0.44
2009 Elphick LM, Lee SE, Anderson AA, Child ES, Bonnac L, Gouverneur V, Mann DJ. Exploring the roles of protein kinases using chemical genetics. Future Medicinal Chemistry. 1: 1233-41. PMID 21426100 DOI: 10.4155/Fmc.09.50  0.44
2009 Elphick LM, Lee SE, Child ES, Prasad A, Pignocchi C, Thibaudeau S, Anderson AA, Bonnac L, Gouverneur V, Mann DJ. A quantitative comparison of wild-type and gatekeeper mutant cdk2 for chemical genetic studies with ATP analogues. Chembiochem : a European Journal of Chemical Biology. 10: 1519-26. PMID 19437469 DOI: 10.1002/Cbic.200900052  0.44
2009 Lee SE, Elphick LM, Anderson AA, Bonnac L, Child ES, Mann DJ, Gouverneur V. Synthesis and reactivity of novel gamma-phosphate modified ATP analogues. Bioorganic & Medicinal Chemistry Letters. 19: 3804-7. PMID 19410453 DOI: 10.1016/J.Bmcl.2009.04.028  0.44
2009 Ju S, McLennan G, Bennett SL, Liang Y, Bonnac L, Pankiewicz KW, Jayaram HN. Technical aspects of imaging and transfemoral arterial treatment of N1-S1 tumors in rats: an appropriate model to test the biology and therapeutic response to transarterial treatments of liver cancers. Journal of Vascular and Interventional Radiology : Jvir. 20: 410-4. PMID 19167243 DOI: 10.1016/J.Jvir.2008.12.408  0.44
2007 Bonnac LF, Gao GY, Chen L, Patterson SE, Jayaram HN, Pankiewicz KW. Efficient synthesis of benzamide riboside, a potential anticancer agent. Nucleosides, Nucleotides & Nucleic Acids. 26: 1249-53. PMID 18066762 DOI: 10.1080/15257770701528222  0.44
2007 Chen L, Gao G, Felczak K, Bonnac L, Patterson SE, Wilson D, Bennett EM, Jayaram HN, Hedstrom L, Pankiewicz KW. Probing binding requirements of type I and type II isoforms of inosine monophosphate dehydrogenase with adenine-modified nicotinamide adenine dinucleotide analogues. Journal of Medicinal Chemistry. 50: 5743-51. PMID 17958343 DOI: 10.1021/Jm070568J  0.44
2007 Bonnac L, Gao GY, Chen L, Felczak K, Bennett EM, Xu H, Kim T, Liu N, Oh H, Tonge PJ, Pankiewicz KW. Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry Letters. 17: 4588-91. PMID 17560106 DOI: 10.1016/J.Bmcl.2007.05.084  0.44
2007 Chen L, Gao G, Bonnac L, Wilson DJ, Bennett EM, Jayaram HN, Pankiewicz KW. Methylenebis(sulfonamide) linked nicotinamide adenine dinucleotide analogue as an inosine monophosphate dehydrogenase inhibitor. Bioorganic & Medicinal Chemistry Letters. 17: 3152-5. PMID 17395461 DOI: 10.1016/J.Bmcl.2007.03.035  0.44
2007 Suk DH, Bonnac L, Dykstra CC, Pankiewicz KW, Patterson SE. Rational design and synthesis of novel nucleotide anti-Giardia agents. Bioorganic & Medicinal Chemistry Letters. 17: 2064-7. PMID 17258459 DOI: 10.1016/J.Bmcl.2007.01.014  0.44
2007 Bonnac L, Chen L, Pathak R, Gao G, Ming Q, Bennett E, Felczak K, Kullberg M, Patterson SE, Mazzola F, Magni G, Pankiewicz KW. Probing binding requirements of NAD kinase with modified substrate (NAD) analogues. Bioorganic & Medicinal Chemistry Letters. 17: 1512-5. PMID 17258457 DOI: 10.1016/J.Bmcl.2007.01.012  0.44
2006 Chen L, Rejman D, Bonnac L, Pankiewicz KW, Patterson SE. Nucleoside-5'-phosphoimidazolides: reagents for facile synthesis of dinucleoside pyrophosphates. Current Protocols in Nucleic Acid Chemistry / Edited by Serge L. Beaucage ... [Et Al.]. Unit 13.4. PMID 18428947 DOI: 10.1002/0471142700.Nc1304S23  0.44
Show low-probability matches.